Continuity Biosciences
Medtech
Continuity Biosciences S.r.l. is a clinical-stage biotech startup developing next-generation implantable platforms for controlled and sustained drug delivery, cell reprogramming, and immune modulation.
Its technologies include nanofluidic implants, 3D-printed devices for cell therapies, systems for the localized treatment of solid tumors, and 3D-printed microneedle technologies. Clinical applications range from type 1 diabetes to HIV prophylaxis, cancer immunotherapy, and aesthetic and cosmetic applications.
-
Foundation date
2024 -
Website
-
Social